Bio-Path Stock Price (NASDAQ:BPTH)

Add to My Stocks
$0.4 $0 (0%) BPTH stock closing price Jul 20, 2017 (Closing)
Prev Close* : $0.40
Market Cap:
Day Low: $0.38
52 Week Low: $0.33
Open: $0.41
Volume: 436462
Day High: $0.41
52 Week High: $1.75

Latest Stock Market News

Latest Articles

Bio-Path News - From Partners

BPTH Stockcharts

View BPTH PE ratio, PS ratio stocks charts and compare with peers.
BPTH Chart
Note: Compare Bio-Path stock price history with the index and industry peers.

BPTH Industry Peers

Company Price Change (%)
Trillium Therapeutics (TRIL)4.850.2 (4.3%)
Nivalis Therapeutics (NVLS)2.390.07 (3.02%)
Ariad Pharma (ARIA)23.990 (0%)
Macrogenics (MGNX)17.430.1 (0.58%)
Seattle Genetics (SGEN)54.140.14 (0.26%)
Stemline Therapeutics (STML)10.10.25 (2.54%)
Pdl Biopharma (PDLI)2.390.03 (1.24%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Tetraphase Pharmaceuticals (TTPH)7.870.46 (6.21%)
Esperion Therapeutics (ESPR)48.82.6 (5.63%)
PTC Therapeutics (PTCT)20.340.91 (4.68%)
GlycoMimetics (GLYC)11.830.52 (4.6%)
MediWound (MDWD)7.250.3 (4.32%)
Catalyst Pharma (CPRX)3.050.12 (4.1%)
Tesaro Inc (TSRO)129.025 (4.03%)
Top gainers from Medical-Drugs industry
* As of Jul 20, 2017
CompanyPriceChange (%)
Adamis Pharma (ADMP)4.650.45 (8.82%)
Ironwood Pharma (IRWD)171.55 (8.36%)
Ignyta (RXDX)8.80.4 (4.35%)
Xencor (XNCR)230.62 (2.62%)
Achaogen (AKAO)22.310.47 (2.06%)
Enanta Pharma (ENTA)36.420.6 (1.62%)
Shire (SHPG)160.222.57 (1.58%)
Top losers from Medical-Drugs industry
* As of Jul 20, 2017

Bio-Path Financial Statements

income statement20162015201420132012
Net Sales Or Revenues0.01M----
Net Income-6.75M-5.46M-4.51M-3.26M-2.58M
Total Operating Expense8.48M5.48M4.53M3.26M2.57M
view Bio-Path Holdings Inc income statement
balance sheet20162015201420132012
Total Assets12.19M10.75M15.47M5.07M2.34M
Total Liabilities3.95M0.93M0.56M0.29M0.32M
Shareholders Equity8.24M9.81M14.91M4.78M2.01M
view Bio-Path Holdings Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-0.67M-0.1M0.12M0.08M-0.02M
Net Cash From (Used By) Operating Activities-8.14M-5M-3.81M-2.31M-1.99M
Increase (Decrease) In Prop Plant And Equipment-0.33M--0.12M--
view Bio-Path Holdings Inc cashflow statement

Bio-Path Stock Message Board

An investor needs to spend 0.4 to buy BPTH stock, as the closing Bio-Path stock price is 0.4. Stock price or share price can be used to find the total market value of a company. Bio-Path market cap stands at 37.21M as of 19 Jul, 2017. A value investor must look at the fundamentals of a stock, and perform Bio-Path valuation, even though in the short-term sentiment and current breaking news might affect Bio-Path stock price.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Bio-Path is worth a lot, it will most likely be reflected in an inflated Bio-Path stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 763824 shares were traded with a closing stock price of 0.4 as of 19 Jul, 2017, as can be seen from Bio-Path stock quote. One can view Bio-Path stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Bio-Path stock price history, gives the entire historical data for BPTH stock.